Fig. 3
From: Teriparatide treatment in severe osteoporosis – a controlled 10-year follow-up study
Percentage change in Femoral neck Bone Mineral Density (BMD) (a) and Lumbar spine BMD (b) from treatment start, to 1.5 and 10 years later with teriparatide and placebo treated patients with osteoporosis, respectively. P-levels within each treatment group and number of subjects at each occasion are shown below the diagrams. Mean treatment time was 18 months followed by other bone specific agents in comparable numbers during follow-up in the teriparatide and placebo group, respectively